Comparing melanoma cells being sensitive or resistant to death receptor induced apoptosis by a second-generation TRAIL agonist the model predicted molecular signatures of pro-survival/anti-apoptotic responses in a dynamic manner. The gene discussed is TNFSF10; the disease is melanoma.